Table 2.
Hispanic | African American | ||||
---|---|---|---|---|---|
r | P-value | r | P-value | p-value for interaction | |
Age at follow-up (yrs) | 0.09 | 0.03 | −0.09 | 0.13 | 0.07 |
Liver Density (HU) | 0.84 | <0.0001 | 0.76 | <.0001 | 0.29 |
BMI (kg/m2) | −0.44 | <0.0001 | −0.13 | 0.03 | <.0001 |
VAT (cm3) | −0.43 | <0.0001 | −0.24 | <.0001 | 0.002 |
SAT (cm3) | −0.27 | <0.0001 | −0.07 | 0.27 | <.0001 |
Percent Total Body Fat | −0.07 | 0.09 | 0.06 | 0.30 | 0.02 |
Fasting insulin (mg/dl) | −0.43 | <0.0001 | −0.23 | 0.0001 | <.0001 |
Fasting glucose (mg/dl) | −0.27 | <0.0001 | −0.05 | 0.39 | 0.0001 |
HDL (mg/dl) | 0.38 | <0.0001 | 0.14 | 0.02 | 0.02 |
TG (mg/dl) | −0.30 | <0.0001 | −0.19 | 0.001 | <.0001 |
PAI-1 (ng/ml) | −0.40 | <0.0001 | −0.09 | 0.13 | <.0001 |
ALT (IU/L) | −0.46 | <0.0001 | −0.24 | 0.0001 | 0.0001 |
AST (IU/L) | −0.32 | <0.0001 | −0.17 | 0.003 | 0.02 |
GGT (IU/L) | −0.30 | <0.0001 | −0.22 | 0.0002 | 0.36 |
Insulin Sensitivity Index * | 0.43 | <0.0001 | 0.25 | <.0001 | 0.0007 |
Acute Insulin Response * | −0.22 | <0.0001 | −0.08 | 0.22 | 0.01 |
Disposition Index * | 0.22 | <0.0001 | 0.15 | 0.01 | 0.002 |
Adiponectin (mg/ml) * | 0.31 | <0.0001 | 0.29 | <.0001 | 0.91 |
CRP (mg/ml) * | −0.27 | <0.0001 | −0.08 | 0.17 | 0.01 |
Data obtained five years prior to NAFLD assessment.